TMC Life Sciences Bhd (XKLS:0101) Ending Cash Position: RM98.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0101 TMC Life Sciences Bhd XKLS:0101
61 GF Score
Price RM0.45
GF Value RM0.63
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd Ending Cash Position?

TMC Life Sciences Bhd XKLS:0101 61 Ending Cash Position is RM98.1 Mil as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 61/100 and a GF Value™ of RM0.63 (Modestly Undervalued). The stock has 3 warning signs investors should review.

TMC Life Sciences Bhd's Ending Cash Position for the quarter that ended in Mar. 2026 was RM98.1 Mil.

TMC Life Sciences Bhd's quarterly Ending Cash Position increased from Sep. 2025 (RM78.2 Mil) to Dec. 2025 (RM91.0 Mil) and increased from Dec. 2025 (RM91.0 Mil) to Mar. 2026 (RM98.1 Mil).

TMC Life Sciences Bhd's annual Ending Cash Position declined from Jun. 2023 (RM116.6 Mil) to Jun. 2024 (RM107.5 Mil) and declined from Jun. 2024 (RM107.5 Mil) to Jun. 2025 (RM60.8 Mil).

TMC Life Sciences Bhd Ending Cash Position Related Terms

TMC Life Sciences Bhd Ending Cash Position Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd Ending Cash Position Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.33 98.89 116.58 107.51 60.82

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.47 60.82 78.22 91.05 98.05
XKLS:0101
61GF Score
TMC Life Sciences Bhd XKLS:0101
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TMC Life Sciences Bhd's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=107.511+-46.689
=60.8

TMC Life Sciences Bhd's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=91.045+7.007
=98.1

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of RM98.1 Mil mean?
TMC Life Sciences Bhd (XKLS:0101) has a Ending Cash Position of RM98.1 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on TMC Life Sciences Bhd and its competitors.
Is TMC Life Sciences Bhd's Ending Cash Position too high?
TMC Life Sciences Bhd's current Ending Cash Position is RM98.1 Mil. Overall, TMC Life Sciences Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Ending Cash Position compare to HCA and THC?
TMC Life Sciences Bhd's Ending Cash Position of RM98.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on TMC Life Sciences Bhd and its competitors. TMC Life Sciences Bhd's current Ending Cash Position is RM98.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.63, compared to a current price of RM0.45 — trading 28.6% below its estimated fair value. The current Ending Cash Position is RM98.1 Mil. TMC Life Sciences Bhd's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Ending Cash Position is RM98.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.45 is trading 28.6% below its estimated GF Value™ of RM0.63. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • Ending Cash Position: RM98.1 Mil
  • GF Value™: RM0.63 vs. price of RM0.45 (28.6% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
61GF Score

Get the complete analysis for XKLS:0101

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.45
Price
RM0.63
GF Value